$1M Gift From Regent, Family to UA Cancer Center
April 14, 2015

The donation from Dr. Ram Krishna and his wife, Meera, will help with the construction of an outpatient facility at the center, scheduled to open in September on the Phoenix Biomedical Campus.

Fishing for Answers
March 24, 2015

Cancer researchers are constantly searching for innovative ways to develop life-saving therapies as quickly as possible. The possible key to unlocking these cures can be found at any pet store throughout the world.

Georg Wondrak, PhD, earns inaugural Director’s Challenge Award
March 11, 2015

Georg Wondrak, PhD, received the UA Cancer Center Director’s Challenge Award for Therapeutic Development.

Meredith Mullins joins UACC as chief administrative officer
March 2, 2015

Meredith Mullins, JD, MBA, has joined the UA Cancer Center as chief administrative officer.

UACC director meets with Phoenix mayor
February 12, 2015

Dr. Andrew S. Kraft recently discussed the role of the University of Arizona Cancer Center on the Phoenix Biomedical Campus with Phoenix Mayor Greg Stanton.

UACC scientist wins BTE grant for breast cancer research
January 22, 2015

Dr. Pavani Chalasani to study biomarkers that might predict therapeutic response for breast cancer patients.

UACC researchers awarded funding from American Cancer Society
January 12, 2015

University of Arizona Cancer Center researchers are working on a variety of cancer projects thanks to funding from the American Cancer Society.

Stacy Lauver joins UACC as finance chief
January 5, 2015

Stacy Lauver, CPA, has joined the University of Arizona Cancer Center as assistant director of finance, coming from Pima  Community College.

UA-discovered drug for skin disease approved for patients in Europe
October 29, 2014

A synthetic hormone developed by UA faculty that has been shown to offer relief for a rare skin disease has been approved for patients in Europe.

UACC and BIO5 researcher awarded $1.59 million NCI grant to study drug resistance in lymphoma tumor treatment
October 20, 2014

Jonathan H. Schatz, MD, was recently awarded a 5-year, $1.59 million grant from the National Cancer Institute (NCI) to study ways to effectively combat drug resistance when treating lymphoma — a study that may have wide-ranging impact when it comes to treating a variety of cancers.